




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































(10.9%)% 18%%% 2.0%% 4.7%
+%20%% 980%(9.8%)%
1180%




(9.0%)% 20%% 1.8%% 4.7%
Y%20%% 640%(6.4%)%
800%






patients* 20%% 15%% 10%% 5%%
5,000% 4.4%% 3.9%% 3.3%% 2.4%%
10,000% 3.1%% 2.8%% 2.3%% 1.7%%
20,000% 2.2%% 1.9%% 1.6%% 1.2%%










5*mg* 10*mg* 20*mg* 40*mg* 80*mg*
Pravastatin% 15%% 20%% 24%% 29%% 33%%
Simvastatin% 23%% 27%% 32%% 37%% 42%%
Atorvastatin% 31%% 37%% 43%% 49%% 55%%




































































































































































































































































































































































































































































































































































































































































































































































































































  < 2.5 5256 4.3 0.78 (0.69 − 0.89)
 ≥ 2.5, < 3.0 4182 4.0 0.77 (0.70 − 0.85)
 ≥ 3, < 3.5 4604 4.1 0.76 (0.70 − 0.82)
 ≥ 3.5 10563 3.9 0.80 (0.77 − 0.84)
 ≤ 65 13623 3.6 0.78 (0.75 − 0.82)
 > 65, ≤ 75 9211 4.6 0.79 (0.74 − 0.83)
 > 75 2123 5.5 0.87 (0.76 − 0.99)
 Male 19922 4.4 0.78 (0.75 − 0.81)
 Female 5035 3.0 0.84 (0.78 − 0.91)
 CHD 19097 5.6 0.79 (0.76 − 0.82)
 Non−CHD vascular 1529 3.7 0.83 (0.73 − 0.94)
 None 4331 1.8 0.75 (0.69 − 0.82)
 Type 1 diabetes 337 6.0 0.77 (0.58 − 1.01)
 Type 2 diabetes 5621 5.1 0.80 (0.74 − 0.86)
 No diabetes 18862 4.0 0.78 (0.76 − 0.82)
 Yes 13939 4.5 0.80 (0.77 − 0.84)
 No 10471 3.5 0.77 (0.73 − 0.81)
 Current smokers 5225 4.7 0.79 (0.73 − 0.85)
 Non−smokers 19728 3.9 0.79 (0.76 − 0.82)
  < 5% 421 0.6 0.62 (0.47 − 0.81)
 ≥ 5, < 10% 1453 1.6 0.69 (0.60 − 0.79)
 ≥ 10, < 20% 7810 3.5 0.79 (0.74 − 0.85)
 ≥ 20, < 30% 9028 5.8 0.81 (0.77 − 0.86)
 ≥ 30% 6245 9.8 0.79 (0.74 − 0.84)
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ic scale: linear association
Mean 1−year LDL cholesterol difference































0.0 0.5 1.0 1.5
5 trials with further
LDL−c reduction
(average: 0.5 mmol/L)
17 trials with LDL−c reduction
at 1 year <1.1 mmol/L
(average: 0.9 mmol/L)
5 trials with LDL−c reduction
at 1 year >1.1 mmol/L
(average: 1.4 mmol/L)







RR (CI) per 1 mmol/L
reduction in LDL−C





 0−1 year 4680 3.8 0.91 (0.85 − 0.97)
 1−2 years 3580 3.4 0.78 (0.73 − 0.85)
 2−3 years 3124 3.6 0.76 (0.70 − 0.82)
 3−4 years 2483 3.6 0.72 (0.66 − 0.79)
 4−5 years 1819 3.7 0.78 (0.71 − 0.87)
 5+ years 1018 3.9 0.76 (0.65 − 0.87)
 All years 16704 3.6 0.80 (0.78 − 0.82)
 Years 1−5+ 12024 3.6 0.76 (0.74 − 0.79)





























Major vascular events avoided  
per 10,000 patients treated for 5-years 
LD














RR (CI) per 1 mmol/L
reduction in LDL−C





4192 0.6Coronary 0.80 (0.74 − 0.87)
4076 0.6Other cardiac 0.92 (0.85 − 0.99)
1054 0.1Stroke 0.98 (0.83 − 1.15)
855 0.1Other vascular 0.95 (0.80 − 1.14)
10177 1.5Any vascular 0.88 (0.84 − 0.91)
3683 0.5Cancer 0.99 (0.91 − 1.09)
538 0.1Respiratory 0.86 (0.70 − 1.06)
275 0.0Trauma 0.97 (0.70 − 1.34)
1748 0.2Other non−vascular 0.94 (0.82 − 1.07)
6244 0.9Any non−vascular 0.96 (0.92 − 1.01)
1036 0.1Unknown 0.87 (0.74 − 1.04)
17457 2.5Any death 0.91 (0.88 − 0.93)








RR (CI) per 1 mmol/L
reduction in LDL−C





1116 0.2Large bowel/intestine 0.95 (0.82 − 1.11)
1343 0.2Other GI 0.99 (0.86 − 1.15)
1877 0.4Prostate 0.97 (0.85 − 1.10)
646 0.1Bladder 0.94 (0.76 − 1.16)
797 0.1Other GU 1.05 (0.86 − 1.27)
1692 0.2Respiratory 1.00 (0.88 − 1.14)
517 0.3Female Breast 1.09 (0.85 − 1.39)
614 0.1Haematological 1.03 (0.83 − 1.28)
1829 0.2Other/unspecified 1.05 (0.92 − 1.21)
10431 1.5Any cancer 1.00 (0.96 − 1.04)
